The CCA is your source for current and reliable research. Check out these newly published research articles:
- ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients’ Tolerance of Gluten
- Genetic Overlap Between Autoimmune Disease and NHL Not Supported by Genome-Wide Association Study
- Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
- World’s first diagnostic blood test for celiac disease in sight
- The National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase
- Why people with celiac disease suffer so soon after eating gluten
- New study calls for screening of family members of celiac disease patients
